EO-3021

· Elevation Oncology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EO-3021, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 [Phase 1]